21-Gene recurrence score influences the chemotherapy decision for patients with breast cancer of different luminal subtypes

Luminal subtypes and the 21-gene recurrence score (RS) are important factors in the decision-making process for adjuvant chemotherapy in patients with hormonal receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer. However, their effect on adjuvant chemotherap...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Lett
Hlavní autoři: Wang, Wei, Lin, Lin, Fei, Xiaochun, Hong, Jin, Gao, Weiqi, Zhu, Siji, Wu, Jiayi, Huang, Ou, He, Jianrong, Li, Yafen, Zhu, Li, Chen, Weiguo, Chen, Xiaosong, Shen, Kunwei
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2019
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6757308/
https://ncbi.nlm.nih.gov/pubmed/31579428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10766
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky